CONTEXT THERAPEUTICS INC. Effective Income Tax Rate Reconciliation, Tax Exempt Income, Percent
CONTEXT THERAPEUTICS INC. (CNTX) reported Effective Income Tax Rate Reconciliation, Tax Exempt Income, Percent of 0.00% for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-22.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome · last filed 2023-03-22
- CONTEXT THERAPEUTICS INC. effective income tax rate reconciliation, tax exempt income, percent for fiscal 2022 was 0.00%, a 100.00% decline from fiscal 2021.
- CONTEXT THERAPEUTICS INC. effective income tax rate reconciliation, tax exempt income, percent for fiscal 2021 was 7.50%, a 70.59% decline from fiscal 2020.
- CONTEXT THERAPEUTICS INC. effective income tax rate reconciliation, tax exempt income, percent for fiscal 2020 was 25.50%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Exempt Income, Percent 12 month |
|---|---|
| 2022-12-31 | 0.00% 10-K · filed 2023-03-22 |
| 2021-12-31 | 7.50% 10-K · filed 2023-03-22 |
| 2020-12-31 | 25.50% 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |